Biovotion exhibiting and presenting at HiMSS Europe
Biovotion at Goldman Sachs Disruptive Tech Symposium
Biovotion to present at MedtechandMoney in London
Biovotion at JPM conference in San Francisco
Biovotion to exhibit at Medica
Final closing Series A
Biovotion appoints new Chairman of the Board
Biovotion registered Everion® with FDA as medical device
Goldman Sachs Disruptive Tech Symposium
Regulatory clearance and manufacturing
Biovotion’s journey – Interview by Junto Health
Biovotion at Mobile World Congress with Altran
Winner Deal of the Year 2016
2nd closing of ongoing Series A
Medica, we are coming!
Health monitoring: Make sense of sensors
Biovotion to present at Health 2.0 S. Clara
Biovotion goes Kilimanjaro
VSM1 going to action...
Biovotion goes Swiss Alpine with VSM1
Biovotion @ Viva Tech Paris-Novartis section
Swiss Re lead investor in Series A
2016 Red Herring Top 100 Europe Winner
2016 Red Herring Top 100 Europe Finalist
Biovotion becomes ISO13485 certified
Biovotion to speak at WEBIT on Digital health
Askmen from WTS 2016
Wearable Technology Show 2016 London
Biovotion in Goldman Sachs Report
No wearable, no policy?
Biovotion’s solutions connect patients and providers throughout the continuum of care.
From primary to hospital and home care. Dedicated, disease specific solutions for better health outcomes.
Biovotion’s wearable monitoring supports you in sustaining a healthy lifestyle and your performance.
Discreet and secure.
Proactively maintain health and discover how quality of your sleep and stress levels change.
Towards predictive intelligent health monitoring
Codified expert knowledge provides insights based on clinical grade information.
Meaningful information helps improve care, and reduces patient and family stress.
Save costs by reducing critical episodes.
Easy to use
Automatic connection and operation. Wireless charging.
Attach the device and band with one hand easily around your arm.